Characterisation of drug resistance in field-collected schistosomes

现场收集的血吸虫的耐药性特征

基本信息

  • 批准号:
    10405578
  • 负责人:
  • 金额:
    $ 15.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-14 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Large-scale treatment programs with praziquantel (PZQ) monotherapy are the mainstay of efforts to control and eliminate schistosomiasis. The potential for drug resistance in schistosomes is a critical area of research as we scale up treatment coverage. In the laboratory, PZQ resistance (PZQ-R) is easily selected, results in a >368-fold difference in drug response, and genetic analyses unambiguously identify a region of chr. 3 containing a transient receptor potential (TRP) channel. In Western Kenya, approximately 30% of schistosome-infected patients are egg-positive following treatment with PZQ, and in a recent study (SCORE) we observed several “hotspot” villages that failed to lower infection intensities and prevalence, despite multiple annual mass treatments with PZQ. One hypothesis is that PZQ-R contributes to the observed failure of mass PZQ treatment to lower infection. In aim 1 we will ask whether the persistence of infection in “hotspot” villages can be explained by resistance. We have established a novel platform for testing for the extent of PZQ-R in individual adult schistosomes from a field setting. To do this we have established a large snail breeding colony, and hamster breeding facility. We can therefore generate large populations of field-derived adult worms, by (i) harvesting S. mansoni eggs from infected patients, (ii) infecting snails with miracidia, (iii) infecting hamsters with released cercariae, and (iv) perfusing adult worms from hamsters. We will screen the drug response of individual S. mansoni worms maintained on 96-well plates and exposed to PZQ using a simple L-Lactate assay. Using this approach, we will directly compare resistance status of parasites from hotspot and non-hotspot villages. We will also compare pools of PZQ-R and PZQ-S parasites isolated from the field to determine the genome regions that underlie the differences observed, and to test the hypothesis that genetic variation in the TRP channel on chr. 3 underlies PZQ resistance in the field. In aim 2 we will exploit our unique platform to examine genetic variation for resistance to new schistosome drugs. A suite of compounds showing strong activity against schistosomes is now available. Recent field studies have shown high levels of naturally occurring resistance to oxamniquine in East Africa where this drug has been minimally used, and comparable work with the free-living nematode C. elegans shows naturally occurring resistance to a range of anthelmintic compounds. We will critically test the hypothesis that “standing variation” for resistance is common against schistosome drugs under development. We will then compare individual worms at the extremes of the drug response spectrum to identify the genetic basis of resistance. The knowledge gained will be critical to on- going schistosomiasis elimination efforts through mass PZQ treatment and will provide valuable information for the development of new anti-schistosome drugs. The project will also stimulate development of research capacity in genome sequencing, computational biology and anthelminthic pharmacology in Kenya.
大规模的吡喹酮(PZQ)单药治疗项目是控制 消灭血吸虫病微囊体中耐药性的潜力是药物治疗的关键领域。 研究,因为我们扩大治疗覆盖面。在实验室中,PZQ抗性(PZQ-R)易于选择, 导致药物反应的差异>368倍,遗传分析明确确定了一个区域, Chr. 3含有瞬时受体电位(TRP)通道。在肯尼亚西部, 在最近的一项研究中, (SCORE)我们观察了几个未能降低感染强度和流行率的“热点”村庄, 尽管每年都用PZQ进行大量治疗。一种假设是PZQ-R有助于 观察到大规模PZQ治疗未能降低感染。在目标1中,我们会问, “热点”村庄的感染率可以用耐药性来解释。我们建立了一个小说 该平台用于测试来自田间环境的个体成体染色体中PZQ-R的程度。这么做 我们建立了一个大型的蜗牛繁殖区和仓鼠繁殖设施。因此我们可以 通过(i)收获S.感染的曼氏菌卵 患者,(ii)用毛蚴感染蜗牛,(iii)用释放的尾蚴感染仓鼠,和(iv)灌注 仓鼠体内的蠕虫我们将筛选个体S的药物反应。曼氏蠕虫 在96孔板上,并使用简单的L-乳酸测定暴露于PZQ。通过这种方式,我们将直接 比较热点和非热点村寄生虫的耐药状况。我们还将比较游泳池 的PZQ-R和PZQ-S寄生虫分离的领域,以确定基因组区域的基础上, 观察到的差异,并测试假设,在TRP通道的遗传变异的chr。 是PZQ耐药性的基础。在aim 2中,我们将利用我们独特的平台来检查遗传 对新药物的耐药性变异。一组显示出强活性的化合物 现在可以使用了。最近的实地研究表明, 在东非,这种药物的使用最少, 自由生活的线虫C.秀丽线虫对一系列驱虫药显示出天然的抗性, 化合物.我们将批判性地检验这一假设,即抗性的“常设变异”是常见的, 一些药物正在开发中。然后,我们将比较药物极端情况下的单个蠕虫 反应谱,以确定抗性的遗传基础。获得的知识将是至关重要的- 通过大规模PZQ治疗消除血吸虫病的努力,将提供有价值的信息 用于开发新的抗肿瘤药物。该项目还将促进研究的发展 在肯尼亚,基因组测序、计算生物学和驱虫药理学能力得到加强。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Makuto Ndombi其他文献

Eric Makuto Ndombi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Makuto Ndombi', 18)}}的其他基金

Characterisation of drug resistance in field-collected schistosomes
现场收集的血吸虫的耐药性特征
  • 批准号:
    10217347
  • 财政年份:
    2021
  • 资助金额:
    $ 15.71万
  • 项目类别:
Characterisation of drug resistance in field-collected schistosomes
现场收集的血吸虫的耐药性特征
  • 批准号:
    10613554
  • 财政年份:
    2021
  • 资助金额:
    $ 15.71万
  • 项目类别:

相似海外基金

African Rare Diseases Initiative (ARDI): Advancing Genomic Medicine through rare diseases research in Africa
非洲罕见疾病倡议 (ARDI):通过非洲罕见疾病研究推进基因组医学
  • 批准号:
    10674660
  • 财政年份:
    2023
  • 资助金额:
    $ 15.71万
  • 项目类别:
French foreign policy in West-Africa revisited: examining French monetary and military influence on African sovereignty
重新审视法国在西非的外交政策:审视法国货币和军事对非洲主权的影响
  • 批准号:
    2887041
  • 财政年份:
    2023
  • 资助金额:
    $ 15.71万
  • 项目类别:
    Studentship
Seamen from the African Indian Ocean, 1880s-1940s: Transnational Labour Relations between Africa and Europe in Colonial Times
来自非洲印度洋的海员,1880 年代至 1940 年代:殖民时期非洲和欧洲之间的跨国劳资关系
  • 批准号:
    23K00793
  • 财政年份:
    2023
  • 资助金额:
    $ 15.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Role of Kaiso as a predictive breast cancer biomarker in Africa and across the African Diaspora
Kaiso 作为非洲和整个非洲侨民的乳腺癌预测生物标志物的作用
  • 批准号:
    10347874
  • 财政年份:
    2022
  • 资助金额:
    $ 15.71万
  • 项目类别:
Pan-African Frontiers And Identities: The Remaking Of Africa In World Politics
泛非边界和身份:世界政治中非洲的重塑
  • 批准号:
    MR/W012103/1
  • 财政年份:
    2022
  • 资助金额:
    $ 15.71万
  • 项目类别:
    Fellowship
Southern African Research Consortium for Mental health INTegration (S-MhINT)-Research and capacity building consortium to strengthen mental health integration in South Africa, Mozambique and Tanzania.
南部非洲心理健康一体化研究联盟 (S-MhINT) - 研究和能力建设联盟,旨在加强南非、莫桑比克和坦桑尼亚的心理健康一体化。
  • 批准号:
    10613603
  • 财政年份:
    2022
  • 资助金额:
    $ 15.71万
  • 项目类别:
The timing and geography of African ape and human origins: New evidence from Europe, Africa and Asia.
非洲猿和人类起源的时间和地理:来自欧洲、非洲和亚洲的新证据。
  • 批准号:
    RGPIN-2016-06761
  • 财政年份:
    2021
  • 资助金额:
    $ 15.71万
  • 项目类别:
    Discovery Grants Program - Individual
The definition of "Africa" and the concept of "race" in Pan-African movements
“非洲”的定义与泛非运动中的“种族”概念
  • 批准号:
    20K22009
  • 财政年份:
    2020
  • 资助金额:
    $ 15.71万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Re-examining the anti-colonial discourses in former Portuguese Africa: How African press argued
重新审视前葡属非洲的反殖民话语:非洲媒体如何争论
  • 批准号:
    20K12353
  • 财政年份:
    2020
  • 资助金额:
    $ 15.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The timing and geography of African ape and human origins: New evidence from Europe, Africa and Asia.
非洲猿和人类起源的时间和地理:来自欧洲、非洲和亚洲的新证据。
  • 批准号:
    RGPIN-2016-06761
  • 财政年份:
    2020
  • 资助金额:
    $ 15.71万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了